Query psy8502
Match_columns 168
No_of_seqs 274 out of 1694
Neff 7.3
Searched_HMMs 29240
Date Fri Aug 16 20:36:24 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy8502.a3m -d /work/01045/syshi/HHdatabase/pdb70.hhm -o /work/01045/syshi/hhsearch_pdb/8502hhsearch_pdb -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 2ks9_A Substance-P receptor; w 99.4 8.7E-13 3E-17 107.9 12.0 70 96-165 33-102 (364)
2 4grv_A Neurotensin receptor ty 99.4 2.9E-13 9.8E-18 117.3 7.0 73 93-165 30-107 (510)
3 3uon_A Human M2 muscarinic ace 99.4 1E-12 3.6E-17 110.5 9.5 74 92-165 20-93 (467)
4 2lnl_A C-X-C chemokine recepto 99.4 1.8E-12 6.1E-17 103.7 10.3 71 94-166 10-80 (296)
5 2rh1_A Beta-2-adrenergic recep 99.3 1.8E-12 6E-17 111.7 8.7 74 92-165 37-110 (500)
6 1u19_A Rhodopsin; G protein-co 99.3 8.2E-12 2.8E-16 101.0 10.9 74 92-165 35-108 (349)
7 4dkl_A MU-type opioid receptor 99.3 6.4E-12 2.2E-16 105.4 9.6 73 92-165 14-86 (464)
8 3pbl_A D(3) dopamine receptor, 99.3 4.5E-12 1.5E-16 107.1 7.8 72 94-165 37-109 (481)
9 3rze_A Histamine H1 receptor, 99.3 7.4E-12 2.5E-16 104.8 7.9 72 94-165 7-78 (452)
10 4amj_A Beta-1 adrenergic recep 99.2 9.4E-12 3.2E-16 98.9 6.3 72 94-165 10-81 (315)
11 3odu_A C-X-C chemokine recepto 99.2 3.5E-11 1.2E-15 102.2 9.6 73 91-165 44-116 (502)
12 3vw7_A Proteinase-activated re 99.2 2.2E-11 7.5E-16 102.9 8.3 74 91-165 16-90 (484)
13 3v2y_A Sphingosine 1-phosphate 99.2 2.7E-11 9.3E-16 105.0 9.0 69 96-165 64-132 (520)
14 3sn6_R Lysozyme, beta-2 adrene 99.2 2.8E-11 9.6E-16 104.4 8.9 74 92-165 179-252 (514)
15 4ea3_A Fusion protein of nocic 99.2 3.9E-11 1.3E-15 101.3 8.4 74 91-165 121-194 (434)
16 3eml_A Human adenosine A2A rec 99.2 5.2E-11 1.8E-15 100.4 8.2 69 94-164 20-88 (488)
17 2z73_A Rhodopsin; visual pigme 99.1 1.9E-10 6.5E-15 97.0 8.8 72 94-165 33-105 (448)
18 4eiy_A Adenosine receptor A2A/ 99.1 1.4E-10 4.8E-15 96.9 7.2 69 94-164 30-98 (447)
19 2lot_A Apelin receptor; membra 96.6 0.00018 6.1E-09 46.0 -1.4 30 97-126 30-59 (64)
20 2kdt_A Neuroendocrine converta 39.4 6 0.00021 22.7 -0.1 27 8-35 14-40 (45)
21 2ks1_B Epidermal growth factor 20.1 1.3E+02 0.0045 17.0 4.1 9 117-125 31-39 (44)
No 1
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A
Probab=99.44 E-value=8.7e-13 Score=107.91 Aligned_cols=70 Identities=26% Similarity=0.450 Sum_probs=64.5
Q ss_pred hHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCCC
Q psy8502 96 ITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLKS 165 (168)
Q Consensus 96 ~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG~ 165 (168)
.++.+++.+++++|++||+++++++.+++++|+++|+|++|||++|++.+++.+|..+.....+.|.+|+
T Consensus 33 ~~~~~~~~~i~~~gi~gN~lvi~vi~~~~~l~~~~~~~l~~LaiaDll~~~~~~p~~~~~~~~~~~~~~~ 102 (364)
T 2ks9_A 33 VLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGL 102 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCCCHHHHHHHHHHHHHHHHHHTHHHHHHHHHHHTSCSSCH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhcccccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCccchH
Confidence 4457888999999999999999999999999999999999999999999999999999888889999885
No 2
>4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus}
Probab=99.40 E-value=2.9e-13 Score=117.29 Aligned_cols=73 Identities=26% Similarity=0.514 Sum_probs=61.7
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCC---CchhHHHHHHHHHHHHHHHhhhhhHHHHHHhh--CCCcCCC
Q psy8502 93 GVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRM---RNVTNYFIVNLAVADMLVITLCLPATLMANIY--VHFDLKS 165 (168)
Q Consensus 93 ~~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l---~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~--~~W~fG~ 165 (168)
..++++.++|++++++|++||++|++++.++|++ |+++|+||+|||++|++++++++|+.+...+. +.|.||+
T Consensus 30 ~~~v~~~~~~~~i~~~g~~gN~lvi~~i~~~~~~r~~~~~~n~~i~~La~aDll~~~~~~p~~~~~~~~~~~~w~~g~ 107 (510)
T 4grv_A 30 YSKVLVTAIYLALFVVGTVGNSVTLFTLARKKSLQSLQSTVHYHLGSLALSDLLILLLAMPVELYNFIWVHHPWAFGD 107 (510)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHTSCC----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCCSSCSSHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhhheeeecCCCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCEEhhH
Confidence 4567778899999999999999999999887654 47899999999999999999999999887765 5699986
No 3
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A*
Probab=99.39 E-value=1e-12 Score=110.46 Aligned_cols=74 Identities=19% Similarity=0.329 Sum_probs=68.0
Q ss_pred CchhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCCC
Q psy8502 92 PGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLKS 165 (168)
Q Consensus 92 ~~~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG~ 165 (168)
.....++.+++.+++++|++||+++++++.+++++|+++|+|++|||++|++++++.+|..+.....+.|.+|+
T Consensus 20 ~~~~~~~~~~~~~~~~~g~~gN~lvi~~~~~~~~~~~~~~~~l~~La~aDll~~~~~~p~~~~~~~~~~~~~~~ 93 (467)
T 3uon_A 20 TFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGP 93 (467)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCGGGCSHHHHHHHHHHHHHHHHHHTHHHHHHHHHHSSSCCSCH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHheeeeeecCccCchhHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCccCCc
Confidence 34557778889999999999999999999999999999999999999999999999999999999999999885
No 4
>2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens}
Probab=99.39 E-value=1.8e-12 Score=103.66 Aligned_cols=71 Identities=37% Similarity=0.570 Sum_probs=61.5
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCCCC
Q psy8502 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLKSL 166 (168)
Q Consensus 94 ~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG~~ 166 (168)
.+.+..++|.+++++|++||++|++++.++|++|+++|+|++|||++|++++ +.+|..+.... .+|.+|+.
T Consensus 10 ~~~i~~i~y~ii~i~gv~gN~lvi~vi~~~~~lrt~~n~~i~nLAvaDll~~-l~~p~~~~~~~-~~~~~~~~ 80 (296)
T 2lnl_A 10 NKYVVIIAYALVFLLSLLGNSLVMLVILYSRVGRSVTDVYLLNLALADLLFA-LTLPIWAASKV-NGWIFGTF 80 (296)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCCSTTHHHHHHHHHHHHHHH-HHHHHHHHHHH-SSSCCSSH
T ss_pred hHHhHHHHHHHHHHHHHHHHHHHHHHHHHccCCCChHHHHHHHHHHHHHHHH-HhhhHHHhhcc-CCCccchh
Confidence 4567778899999999999999999999999999999999999999999986 56787766554 56999863
No 5
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A*
Probab=99.35 E-value=1.8e-12 Score=111.68 Aligned_cols=74 Identities=26% Similarity=0.335 Sum_probs=67.5
Q ss_pred CchhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCCC
Q psy8502 92 PGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLKS 165 (168)
Q Consensus 92 ~~~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG~ 165 (168)
+....++.+++.+++++|++||+++++++.+++++|+++|+|++|||++|++++++.+|+.+...+.+.|.+|+
T Consensus 37 ~~~~~~~~~~~~~i~~~gi~gN~lvi~~i~~~~~l~~~~~~~l~nLAiaDll~~~~~~p~~~~~~~~~~w~~~~ 110 (500)
T 2rh1_A 37 EVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGN 110 (500)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCGGGCSHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHTSCCSHH
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCccCcccHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCcCCc
Confidence 34456677889999999999999999999999999999999999999999999999999999999899999985
No 6
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ...
Probab=99.33 E-value=8.2e-12 Score=100.98 Aligned_cols=74 Identities=23% Similarity=0.341 Sum_probs=66.7
Q ss_pred CchhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCCC
Q psy8502 92 PGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLKS 165 (168)
Q Consensus 92 ~~~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG~ 165 (168)
+....++.+++.+++++|++||+++++++.+++++|+++|++++|||++|++.+++.+|..+.....+.|.+|+
T Consensus 35 ~~~~~~~~~~~~~i~~~gi~gN~lvi~~i~~~~~~~~~~~~ll~~Lai~Dll~~~~~~~~~~~~~~~~~~~~~~ 108 (349)
T 1u19_A 35 PWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFGP 108 (349)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCCSHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHTSCTTHH
T ss_pred hHHHHHHHHHHHHHHHHHHHhHHheEeehhhhhhhcCchhHHHHHHHHHHHHHHHhcchHHHHHHhcCeeeCCh
Confidence 34456777888999999999999999999999999999999999999999999998999999888889998875
No 7
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A*
Probab=99.31 E-value=6.4e-12 Score=105.35 Aligned_cols=73 Identities=33% Similarity=0.497 Sum_probs=66.4
Q ss_pred CchhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCCC
Q psy8502 92 PGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLKS 165 (168)
Q Consensus 92 ~~~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG~ 165 (168)
.....++.+++.+++++|++||+++++++.+++++|+++|+|++|||++|++++++ +|+.+...+.+.|.+|+
T Consensus 14 ~~~~~~~~~~~~~~~~~gi~gN~lvi~~~~~~~~~~~~~~~~l~~La~~Dll~~~~-~p~~~~~~~~~~~~~~~ 86 (464)
T 4dkl_A 14 MVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATST-LPFQSVNYLMGTWPFGN 86 (464)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCSTTCSHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHSSCCSCS
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHeehhhhhccccCCHHHHHHHHHHHHHHHHHHH-HHHHHHHHHhCCccccc
Confidence 34567888899999999999999999999999999999999999999999998765 99999999999999986
No 8
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens}
Probab=99.29 E-value=4.5e-12 Score=107.13 Aligned_cols=72 Identities=31% Similarity=0.518 Sum_probs=62.5
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhh-CCCcCCC
Q psy8502 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIY-VHFDLKS 165 (168)
Q Consensus 94 ~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~-~~W~fG~ 165 (168)
...++.+++.+++++|++||+++++++.+++++|+++|+|++|||++|++++++.+|..+...+. +.|.+|.
T Consensus 37 ~~~~~~~~~~~~~~~g~~gN~lvi~~~~~~~~~~~~~~~~l~~La~aDll~~~~~~p~~~~~~~~~~~~~~~~ 109 (481)
T 3pbl_A 37 PHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSR 109 (481)
T ss_dssp ----CCSHHHHHHHHHHHHHHHHHHHHHHCSTTCSHHHHHHHHHHHHHHHHHHHTHHHHHHHHHTTSCCCSCH
T ss_pred chHHHHHHHHHHHHHHHHHHHHHhHHhhhccccCCchHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCccccCc
Confidence 44566778899999999999999999999999999999999999999999999999998887777 6799885
No 9
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens}
Probab=99.27 E-value=7.4e-12 Score=104.82 Aligned_cols=72 Identities=22% Similarity=0.389 Sum_probs=65.4
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCCC
Q psy8502 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLKS 165 (168)
Q Consensus 94 ~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG~ 165 (168)
...++.+++.+++++|++||+++++++.+++++|+++|+|++|||++|++++++.+|..+...+.+.|.+|+
T Consensus 7 ~~~~~~~~~~~~~~~gi~gN~~vi~~~~~~~~~~~~~~~~l~~La~~Dll~~~~~~p~~~~~~~~~~~~~~~ 78 (452)
T 3rze_A 7 QLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGR 78 (452)
T ss_dssp --CGGGTHHHHHHHHHHHHHHHHHHHHHHCSTTCCGGGHHHHHHHHHHHHHHHTHHHHHHHHHHSSSCSSHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhccccCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCccCCc
Confidence 345677888999999999999999999999999999999999999999999999999999999999999875
No 10
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A*
Probab=99.23 E-value=9.4e-12 Score=98.90 Aligned_cols=72 Identities=29% Similarity=0.323 Sum_probs=66.3
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCCC
Q psy8502 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLKS 165 (168)
Q Consensus 94 ~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG~ 165 (168)
.+....+++.+++++|++||+++++++.+++++|+++|+|++|||++|++.+++.+|..+.....+.|.+|+
T Consensus 10 ~~~~~~~~~~~~~~~gi~gN~lvi~~i~~~~~~~~~~~~ll~~LaiaDll~~~~~~p~~~~~~~~~~~~~~~ 81 (315)
T 4amj_A 10 WEAGMSLLMALVVLLIVAGNVLVIAAIGSTQRLQTLTNLFITSLACADLVVGLLVVPFGATLVVRGTWLWGS 81 (315)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHCGGGCCHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHSSCCSCH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhHHhhhchhhcchHHHHHHHHHHHHHHHHHHhccHHHHHHhcCCeeccc
Confidence 456777888999999999999999999999999999999999999999999889999999998899999985
No 11
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B*
Probab=99.22 E-value=3.5e-11 Score=102.17 Aligned_cols=73 Identities=29% Similarity=0.448 Sum_probs=64.1
Q ss_pred CCchhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCCC
Q psy8502 91 SPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLKS 165 (168)
Q Consensus 91 ~~~~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG~ 165 (168)
....+.++.+++.+++++|++||++|++++.+++++|+++|+|++|||++|+++ ++.+|+.+.... +.|.+|+
T Consensus 44 ~~~~~~~~~~~~~~i~~~g~~gN~lvi~~~~~~~~l~~~~~~~l~~La~~Dll~-~~~~p~~~~~~~-~~~~~~~ 116 (502)
T 3odu_A 44 ANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLF-VITLPFWAVDAV-ANWYFGN 116 (502)
T ss_dssp CTTHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTCCSCCHHHHHHHHHHHHHHHH-HTTHHHHHHHHH-TCCCSHH
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccCCCHHHHHHHHHHHHHHHH-HHHHHHHHHHHh-cCCcCCc
Confidence 345567888999999999999999999999999999999999999999999999 578999887665 4798875
No 12
>3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens}
Probab=99.22 E-value=2.2e-11 Score=102.95 Aligned_cols=74 Identities=24% Similarity=0.359 Sum_probs=63.3
Q ss_pred CCchhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhh-CCCcCCC
Q psy8502 91 SPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIY-VHFDLKS 165 (168)
Q Consensus 91 ~~~~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~-~~W~fG~ 165 (168)
.+....++.+++++++++|++||+++++++.+++++|+++|+|++|||++|+++++ ++|..+...+. +.|.+|+
T Consensus 16 ~~~~~~~~~~~~~~i~~~~i~gN~lvi~~~~~~~~l~~~~~~~l~~La~aDll~~~-~~~~~~~~~~~~~~~~~~~ 90 (484)
T 3vw7_A 16 SSWLTLFVPSVYTGVFVVSLPLNIMAIVVFILKMKVKKPAVVYMLHLATADVLFVS-VLPFKISYYFSGSDWQFGS 90 (484)
T ss_dssp CHHHHTHHHHHHHHHHHHHHHHHHHHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHT-THHHHHHHHHTTSCCCSCH
T ss_pred ccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccccCCHHHHHHHHHHHHHHHHHH-HHHHHHHHHHhcCCcccch
Confidence 45566788899999999999999999999999999999999999999999999964 56766666655 4899884
No 13
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A*
Probab=99.22 E-value=2.7e-11 Score=104.96 Aligned_cols=69 Identities=17% Similarity=0.281 Sum_probs=61.9
Q ss_pred hHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCCC
Q psy8502 96 ITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLKS 165 (168)
Q Consensus 96 ~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG~ 165 (168)
.++.+++.+++++|++||++|++++.+++++|+++|+|++|||++|++++++.+|..+.. ..+.|.+|.
T Consensus 64 ~~~~~~~~~i~~~g~~gN~lvi~vi~~~~~lr~~~~~~l~nLA~aDll~~~~~~p~~~~~-~~~~~~~~~ 132 (520)
T 3v2y_A 64 KLTSVVFILICCFIILENIFVLLTIWKTKKFHRPMYYFIGNLALSDLLAGVAYTANLLLS-GATTYKLTP 132 (520)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHCSTTCSHHHHHHHHHHHHHHHHHHHHHHHHHHS-GGGGTTSCH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhCccccChHHHHHHHHHHHHHHHHHHHHHHHHHc-cccceeeCc
Confidence 677889999999999999999999999999999999999999999999998888887765 566787764
No 14
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A*
Probab=99.22 E-value=2.8e-11 Score=104.35 Aligned_cols=74 Identities=26% Similarity=0.332 Sum_probs=67.9
Q ss_pred CchhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCCC
Q psy8502 92 PGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLKS 165 (168)
Q Consensus 92 ~~~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG~ 165 (168)
+....++.+++.+++++|++||+++++++.+++++|+++|+|++|||++|++++++.+|..+...+.+.|.+|+
T Consensus 179 ~~~~~~~~i~~~ii~~~gi~gN~lvi~vi~~~~~lr~~~~~ll~nLAiaDll~~~~~~p~~~~~~~~~~~~~~~ 252 (514)
T 3sn6_R 179 EVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILTKTWTFGN 252 (514)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCGGGCCHHHHHHHHHHHHHHTTTTTHHHHHHHHHHHTSCCSCS
T ss_pred chHHHHHHHHHHHHHHHHHHhHHHhhhheecccccccHHHHHHHHHHHHHHHHHHHhCHHHHHHHHcCCeeCCc
Confidence 44556777889999999999999999999999999999999999999999999999999999999999999986
No 15
>4ea3_A Fusion protein of nociceptin receptor and cytochr; PSI-biology GPCR network, structural genomics, GPCR membrane 7TM NOP ORL1 cytochrome B562; HET: 0NN OLB OLA OLC; 3.01A {Homo sapiens}
Probab=99.19 E-value=3.9e-11 Score=101.29 Aligned_cols=74 Identities=38% Similarity=0.561 Sum_probs=66.8
Q ss_pred CCchhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCCC
Q psy8502 91 SPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLKS 165 (168)
Q Consensus 91 ~~~~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG~ 165 (168)
.+..+.++.+++.+++++|++||+++++++.+++++|+++|+|++|||++|+++ ++++|+.+.....+.|.+|+
T Consensus 121 ~~~~~~~~~~~~~~i~~~gi~gN~lvi~~i~~~~~l~~~~~~ll~~LAvsDll~-~~~~p~~~~~~~~~~~~~~~ 194 (434)
T 4ea3_A 121 PLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLV-LLTLPFQGTDILLGFWPFGN 194 (434)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCHHHHHHHHHHHHHHHH-HTTHHHHHHHHHHTSCTTHH
T ss_pred ChhHHHHHHHHHHHHHHHHHHHHHHeeeeeeecCccCchhHHHHHHHHHHHHHH-HHHhHHHHHHHHhcCCcCcc
Confidence 445667788899999999999999999999999999999999999999999998 78899999999999998874
No 16
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A*
Probab=99.17 E-value=5.2e-11 Score=100.42 Aligned_cols=69 Identities=33% Similarity=0.477 Sum_probs=60.8
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCC
Q psy8502 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLK 164 (168)
Q Consensus 94 ~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG 164 (168)
...++.+++.+++++|++||+++++++.+++++|+++|+|++|||++|++++++.+|+.+.... .|.+|
T Consensus 20 ~~~~~~~~~~~i~~~gi~gN~lvi~~~~~~~~~~~~~~~~l~~La~aDll~~~~~~p~~~~~~~--~~~~~ 88 (488)
T 3eml_A 20 GSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITIST--GFCAA 88 (488)
T ss_dssp TTHHHHHHHHHHHHHHHHHHHHHHHHHHHCGGGCSSHHHHHHHHHHHHHHHHHTHHHHHHHHTT--CCEEC
T ss_pred chhHHHHHHHHHHHHHHHHHHHhhhheeeccccCChHHHHHHHHHHHHHHHHHHHHHHHHHHhc--ccccc
Confidence 4567778899999999999999999999999999999999999999999999999998876543 57665
No 17
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A*
Probab=99.11 E-value=1.9e-10 Score=96.97 Aligned_cols=72 Identities=22% Similarity=0.281 Sum_probs=63.8
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhh-hhHHHHHHhhCCCcCCC
Q psy8502 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLC-LPATLMANIYVHFDLKS 165 (168)
Q Consensus 94 ~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~-~P~~i~~~~~~~W~fG~ 165 (168)
...++.+++.+++++|++||+++++++.++|++|++.|++++|||++|++++++. +|..+...+.+.|.+|+
T Consensus 33 ~~~~~~i~~~ii~i~gi~gN~lvi~vi~~~~~~~~~~~~ll~~LaiaDll~~~~~~~p~~~~~~~~~~~~~~~ 105 (448)
T 2z73_A 33 VYYSLGIFIGICGIIGCGGNGIVIYLFTKTKSLQTPANMFIINLAFSDFTFSLVNGFPLMTISCFLKKWIFGF 105 (448)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHCSTTCSTTHHHHHHHHHHHHHHHHHHSTTHHHHHHHTTSCCSHH
T ss_pred HHHHHHHHHHHHHHHHHhhHHHhhhhhhhccccCCccchHHHHHHHHHHHHHHHHhccHHHHHHhcCCccCCH
Confidence 3455677888999999999999999999999999999999999999999998764 89998888889998874
No 18
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A
Probab=99.09 E-value=1.4e-10 Score=96.88 Aligned_cols=69 Identities=33% Similarity=0.480 Sum_probs=59.9
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHhhHHHhhcCCCCchhHHHHHHHHHHHHHHHhhhhhHHHHHHhhCCCcCC
Q psy8502 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHFDLK 164 (168)
Q Consensus 94 ~~~~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l~~~~~~fi~nLA~aDLl~~~~~~P~~i~~~~~~~W~fG 164 (168)
...+..+++.+++++|++||+++++++.+++++|+++|+|++|||++|++++++.+|..+... ..|.+|
T Consensus 30 ~~~~~~~i~~~i~~~gi~gN~~vl~~~~~~~~l~~~~~~~l~~La~~Dll~~~~~~p~~~~~~--~~~~~~ 98 (447)
T 4eiy_A 30 GSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITIS--TGFCAA 98 (447)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHCGGGCSHHHHHHHHHHHHHHHHHHTHHHHHHHHH--TTCEEE
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHHHHHccccCcHHHHHHHHHHHHHHHHHHHHHHHHHHHh--cccccC
Confidence 445777888999999999999999999999999999999999999999999999999887643 355544
No 19
>2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A
Probab=96.58 E-value=0.00018 Score=45.96 Aligned_cols=30 Identities=37% Similarity=0.527 Sum_probs=26.5
Q ss_pred HHHHHHHHHHHHHHHHHHHhhHHHhhcCCC
Q psy8502 97 TFIIGYLAVFLIGLVGNSLVIAVVIRSPRM 126 (168)
Q Consensus 97 ~~~~~~~ii~l~gl~GN~lvl~~i~~~~~l 126 (168)
++.++|+++|++|++||++|+|++.++|.-
T Consensus 30 ~lp~~Y~lvFvlGl~GN~lvl~v~~~~~~~ 59 (64)
T 2lot_A 30 LIPAIYMLVFLLGTTGNGLVLWTVFRKKGH 59 (64)
T ss_dssp SSHHHHHHTTTTTTTSSSSHHHHHHHHSSS
T ss_pred HHHHHHHHHHHHHHhhhhhheeeeeEeccc
Confidence 667889999999999999999999887753
No 20
>2kdt_A Neuroendocrine convertase 1; secretory granules, prohorme convertase, calcium, cleavage on PAIR of basic residues, cytoplasmic vesicle; NMR {Mus musculus} PDB: 2ke3_A
Probab=39.44 E-value=6 Score=22.67 Aligned_cols=27 Identities=22% Similarity=0.155 Sum_probs=22.9
Q ss_pred CcchhccccccCCCCCchhhhhcccccc
Q psy8502 8 SEYYHIDLSSRDNYGLNTFLLQQGAEDM 35 (168)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 35 (168)
+| |.|-|.||.-+-||--+|+|+--||
T Consensus 14 ~D-y~D~FYntkPYkHRDDrLlQAL~~i 40 (45)
T 2kdt_A 14 SD-YVDVFYNTKPYKHRDDRLLQALMDI 40 (45)
T ss_dssp HH-HHHHHHTCCCSSCSSTTHHHHHHHH
T ss_pred hh-hHhhhhcCCCcccchHHHHHHHHHH
Confidence 44 8899999999999999999986554
No 21
>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}
Probab=20.09 E-value=1.3e+02 Score=17.00 Aligned_cols=9 Identities=22% Similarity=0.486 Sum_probs=4.0
Q ss_pred hHHHhhcCC
Q psy8502 117 IAVVIRSPR 125 (168)
Q Consensus 117 l~~i~~~~~ 125 (168)
++.++++++
T Consensus 31 ~~~~~RRr~ 39 (44)
T 2ks1_B 31 IGLFMRRRH 39 (44)
T ss_dssp HHHHHHTTT
T ss_pred HHHHhhhhH
Confidence 344444443
Done!